Metabolic Syndrome-Associated Periodontal Inflammatory Surface Area
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorRecep Tayyip Erdogan University Training and Research Hospital
About this trial
This study aims to examine the potential of metabolic syndrome (MetS), a systemic, inflammatory disease, to influence the relationship between periodontal inflammatory surface area (PISA) and diabetes and obesity parameters. The primary question addressed by the study is:
Can PISA be used as a significant parameter in the relationship between periodontal disease and MetS? In this context, the relationship between PISA and periodontal clinical parameters and serum parameters directly related to the diagnosis of MetS will be examined.
Eligibility criteria
Qualifiers
Being between 18 and 65 years of age
Presence of at least three of the following parameters: (For MetS diagnosis) Waist circumference: ≥ 94 cm for men, ≥ 88 cm for women Blood pressure ≥ 130/85 mmHg or taking antihypertensive medication Fasting blood glucose ≥ 100 mg/dl or diagnosed with Type 2 Diabetes Triglycerides ≥ 1.7 mmol/L HDL < 1.29 mmol/L
Having at least 20 teeth
Not having received periodontal therapy in the last 6 months
Disqualifiers
Patients with active infectious disease,
Those taking medications that may affect periodontal tissues,
Those who did not sign the informed consent form.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupLocations
1Department of Periodontology of the Faculty of Dentistry of Recep Tayyip Erdogan University53200, RizeRize Province, Turkey (Türkiye)
Sponsors and collaborators
Recep Tayyip Erdogan University Training and Research Hospital
Lead sponsor
Source ClinicalTrials.gov